Biogen (BIIB) option IV into November 29 event

Biogen (NASDAQ: BIIB) November weekly option implied volatility is at 31, December weekly is at 58, December is at 45; compared to its 52-week range of 29 to 97 into data will be peer reviewed and presented Nov. 29 at the Clinical Trials on Alzheimer's Congress.

You May Also Be Interested In

• Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
• Micron Technology (MU) call put ratio 1 call to 1 put into quarter results
• Sandisk (SNDK) call put ratio 1 call to 1.2 puts a focus on June 26 weekly 1290 puts into Korean market weakness and Micron (MU) quarter results